NUTRIBAND INC. - COMMON STOCK

Nutriband CEO Publishes Letter to Shareholders

30 4 2025 07:30:00 提供 Nasdaq GlobeNewswire

Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology

11 4 2025 07:00:00 提供 Nasdaq GlobeNewswire

UPDATE – Nutriband Signs Associate Partnership with Charlotte FC

04 4 2025 17:41:36 提供 Nasdaq GlobeNewswire

Nutriband Signs Partnership Agreement with Charlotte FC

04 4 2025 07:00:00 提供 Nasdaq GlobeNewswire

Nutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development.

21 2 2025 07:00:00 提供 Nasdaq GlobeNewswire

Nutriband and Kindeva Drug Delivery Formalize Exclusive Development Partnership for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch

13 2 2025 07:00:00 提供 Nasdaq GlobeNewswire

Nutriband Inc. Announces Olympian Anastasia Nichita to Advisory Board

11 2 2025 09:00:00 提供 Nasdaq GlobeNewswire

Nutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa™

07 2 2025 08:45:00 提供 Nasdaq GlobeNewswire

Nutriband Issues Letter to Shareholders

31 12 2024 07:00:00 提供 Nasdaq GlobeNewswire

Nutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal Technology

27 12 2024 09:25:00 提供 Nasdaq GlobeNewswire

Nutriband Inc. Quarterly Report Highlights Record Revenue for Q3 up 50.94% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025

04 12 2024 09:00:00 提供 Nasdaq GlobeNewswire

Nutriband Inc. to Present at The 2024 Noble Conference in Boca Raton on December 4th

04 12 2024 07:00:00 提供 Nasdaq GlobeNewswire

Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa™ Abuse Deterrent Transdermal Technology

27 11 2024 07:00:00 提供 Nasdaq GlobeNewswire